Health Reporter French Polynesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Reporter French Polynesia.

Press releases published on October 5, 2026

8 hours ago

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

8 hours ago

Aprea Therapeutics to Present at October Conferences

Indeterminate GlobeNewswire

8 hours ago

Autolus Therapeutics to Present Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026

Indeterminate GlobeNewswire

8 hours ago

DLH Wins $2 Million NIH Data Governance Pilot Task Order

Indeterminate GlobeNewswire

9 hours ago

Coverys Reveals 68% of Inpatient Diagnostic Errors Occur on General Medical-Surgical Units

Indeterminate GlobeNewswire

9 hours ago

Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101

Indeterminate GlobeNewswire

9 hours ago

Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing

Indeterminate GlobeNewswire

9 hours ago

Ensimmäinen potilas on saanut hoitoa Orion Pharman Faasi 1/2 -tutkimuksessa ODM-216-molekyylillä, joka on yhtiön ensimmäinen kliiniseen kehitysvaiheeseen edennyt biologinen syöpälääkeaihio

Indeterminate GlobeNewswire

9 hours ago

PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026

Indeterminate GlobeNewswire

9 hours ago

PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors

Indeterminate GlobeNewswire

9 hours ago

Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins

Indeterminate GlobeNewswire

9 hours ago

4DMT to Host Investor Day on October 21, 2026

Indeterminate GlobeNewswire

9 hours ago

Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026

Indeterminate GlobeNewswire

9 hours ago

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer

Indeterminate GlobeNewswire

9 hours ago

MAPS and International Alliance of Psychedelic Therapy Practitioners Announce Partnership to Advance Training for Psychedelic-Assisted Therapy

Indeterminate GlobeNewswire

9 hours ago

Cerevance Appoints Karl Kieburtz, M.D., M.P.H., as Chief Medical Officer

Indeterminate GlobeNewswire

9 hours ago

OnCusp Therapeutics Announces Positive Phase 1b Data Evaluating its CDH6-Directed Antibody-Drug Conjugate, CUSP06, in Platinum-Resistant Ovarian Cancer (PROC) Presented at Plenary Oral Session of the IGCS 2026 Annual Global Meeting

Indeterminate GlobeNewswire

9 hours ago

Forward Therapeutics Announces Positive Phase 1 Data for Potential Best-in-Class Oral TNFR1 Signaling Inhibitor FT2109, Supporting Advancement into Phase 2 Development

Indeterminate GlobeNewswire

9 hours ago

TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement

Indeterminate GlobeNewswire

9 hours ago

Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease

Indeterminate GlobeNewswire